Company Data
Anebulo Pharmaceuticals Inc.
Ticker
ANEB
Current Price
$1.05 -2.78%
Market Cap
$43.1M
Price Target
Refer to Report
Volume
3.1K
52wk Range
$0.8001 - $3.08
Overview
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company. It is developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations.